Skip to main content
Federal Circuit· 7/18/2022

Caredx, Inc. v. Natera, Inc.

Citations

  • 40 F.4th 1371

How courts have described this case

Verbatim parenthetical descriptions written by other courts when citing this decision. Ranked by citation-network relevance.

  • holding a claim was not inventive where “each step in the purported invention require[d] only conventional techniques and commercially available technology”
  • affirming the lower court which “recognized that CareDx’s expert testimony and other extrinsic evidence was contrary to, and therefore could not overcome, the admissions in the specification”
  • “These exceptions exist because monopolizing the basic tools of 23 scientific work ‘might tend to impede innovation more than it would tend to promote it.’”
  • “wherein the . . . assay detects the [target] cfDNA . . . when the [target] cfDNA make up at least 0.03% of the total circulating cfDNA in the biological sample”
  • “These exceptions exist because monopolizing the basic tools of scientific work 9 ‘might tend to impede innovation more than it would tend to promote it.’” (quoting Mayo, 10 566 U.S. at 71)
  • “Under Third Circuit law, which governs the procedures by which this case is handled, a district court may revisit a prior decision sua sponte so long as it has not entered a final judgment depriving it of jurisdiction to reconsider the issue.”

Source: CourtListener parenthetical corpus (CC0).

Read full opinion on CourtListener

Cited by

1 case in this archive cites this case.

Cites

13 cases in this archive are cited by this case.

Sourced from CourtListener / Free Law Project (CC0).

This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.